These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7315667)

  • 1. Diphenylhydantoin stimulation of various pathways of hepatic microsomal drug metabolism in rabbits.
    Gut I; Becker BA
    Acta Univ Carol Med (Praha); 1980; 26(1-2):105-14. PubMed ID: 7315667
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of d-propoxyphene and diphenylhydantoin in rat liver microsomal preparation.
    Verebey K
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):21-9. PubMed ID: 663405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphenylhydantoin metabolism by rat liver microsomes and some of the effects of drug or chemical pretreatment on diphenylhydantoin metabolism by rat liver microsomal preparations.
    Kutt H; Fouts JR
    J Pharmacol Exp Ther; 1971 Jan; 176(1):11-26. PubMed ID: 5569630
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of diphenylhydantoin on the drug metabolism and the fatty acid composition of phospholipids in hepatic microsomes.
    Ariyoshi T; Takabatake E
    Chem Pharm Bull (Tokyo); 1972 Jan; 20(1):180-4. PubMed ID: 5014544
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative in vitro and in vivo drug metabolism in major and minor food-producing species.
    Dalvi RR
    Vet Hum Toxicol; 1988; 30 Suppl 1():22-5. PubMed ID: 3212938
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats.
    Yamazaki H; Komatsu T; Takemoto K; Saeki M; Minami Y; Kawaguchi Y; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ Proceedings: Microsomal hydrolases and drug metabolism].
    Krisch K
    Z Klin Chem Klin Biochem; 1975 Aug; 13(8):371. PubMed ID: 1216965
    [No Abstract]   [Full Text] [Related]  

  • 8. Microsomal and parenchymal cell models in multiple drug metabolism.
    Lowery GL; Bidlack WR
    Proc West Pharmacol Soc; 1981; 24():141-5. PubMed ID: 7255437
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug metabolism and toxicity].
    Kitagawa H
    Rinsho Byori; 1973 May; 21(5):413-21. PubMed ID: 4738038
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of age-related changes in hepatic drug metabolism in miniature swine.
    Peggins JO; Shipley LA; Weiner M
    Drug Metab Dispos; 1984; 12(3):379-81. PubMed ID: 6145568
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug metabolism in uremia.
    Reidenberg MM
    Clin Nephrol; 1975; 4(3):83-5. PubMed ID: 1102176
    [No Abstract]   [Full Text] [Related]  

  • 12. The prediction of human clearance from hepatic microsomal metabolism data.
    Obach RS
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):36-44. PubMed ID: 11727321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diphenylhydantoin upon estrogen metabolism by liver microsomes of DDT-treated Japanese quail.
    Bernstein JD; Johnson SL
    Bull Environ Contam Toxicol; 1973 Nov; 10(5):309-14. PubMed ID: 4148808
    [No Abstract]   [Full Text] [Related]  

  • 14. The applicability of in vitro hepatic models in pharmacology.
    Riché C
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():21-2. PubMed ID: 8899688
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of in silico models for fraction of unbound drug in human liver microsomes.
    Gao H; Steyn SJ; Chang G; Lin J
    Expert Opin Drug Metab Toxicol; 2010 May; 6(5):533-42. PubMed ID: 20233033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of microsomal metabolism and binding of enantiomerically related substrates.
    Anders MW; Cooper MJ; Takemori AE
    Drug Metab Dispos; 1973; 1(4):642-4. PubMed ID: 4149638
    [No Abstract]   [Full Text] [Related]  

  • 17. Binding of drugs to hepatic microsomes: comment and assessment of current prediction methodology with recommendation for improvement.
    Hallifax D; Houston JB
    Drug Metab Dispos; 2006 Apr; 34(4):724-6; author reply 727. PubMed ID: 16552024
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of diphenylhydantoin on the liver constituents and the microsomal drug metabolizing enzyme systems in the partially hepatectomized rats (author's transl)].
    Ariyoshi T; Zange M; Remmer H
    Yakugaku Zasshi; 1974 Apr; 94(4):526-30. PubMed ID: 4472711
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of ethanol on hepatic microsomal drug-metabolizing enzymes in the rat.
    Liu SJ; Ramsey RK; Fallon HJ
    Biochem Pharmacol; 1975 Feb; 24(3):369-78. PubMed ID: 1125043
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabolism of drugs. III. Genetic factors inducing and inhibiting metabolism].
    Dyderski S; Grzymisławski M
    Pol Merkur Lekarski; 2005 Apr; 18(106):457-61. PubMed ID: 16161934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.